Results 201 to 210 of about 49,037 (222)

Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention

European Journal of Clinical Microbiology and Infectious Diseases, 2010
A D Hanssen, Wilson W R, J M Steckelberg
exaly  

Rifampin

2005
openaire   +1 more source

Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Administered at 600, 900, and 1,200 Milligrams Daily in Patients with Pulmonary Tuberculosis

Antimicrobial Agents and Chemotherapy, 2017
Cecile Magis-Escurra, Angela Colbers, R E Aarnoutse   +2 more
exaly  

Optimization of the Rifampin Dosage to Improve the Therapeutic Efficacy in Tuberculosis Treatment Using a Murine Model

American Journal of Respiratory and Critical Care Medicine, 2013
Jurriaan De Steenwinkel, Rob Aarnoutse, Henri A Verbrugh   +2 more
exaly  

Role of Rifampin against Staphylococcal Biofilm Infections In Vitro , in Animal Models, and in Orthopedic-Device-Related Infections

Antimicrobial Agents and Chemotherapy, 2019
Parham Sendi, Werner Zimmerli
exaly  

Evolution of Rifampin Resistance in Escherichia coli and Mycobacterium smegmatis Due to Substandard Drugs

Antimicrobial Agents and Chemotherapy, 2019
Muhammad Zaman, Zohar Weinstein
exaly  

Comparison of doxycycline–streptomycin, doxycycline–rifampin, and ofloxacin–rifampin in the treatment of brucellosis: a randomized clinical trial

International Journal of Infectious Diseases, 2012
Mojgan Mamaní, Hossein Mahjub, Mehrdad Hajilooi   +2 more
exaly  

Update on rifampin, rifabutin, and rifapentine drug interactions

Current Medical Research and Opinion, 2013
Timothy Self, Christopher Finch
exaly  

Molecular Logic Gates for DNA Analysis: Detection of Rifampin Resistance in M. tuberculosis DNA

Angewandte Chemie - International Edition, 2012
Dmitry Kolpashchikov, Evan Cornett
exaly  

Rifampin

2018
openaire   +2 more sources